Cellink AB Ownership
CLLKF Stock | USD 3.01 0.31 9.34% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Cellink |
Cellink Pink Sheet Ownership Analysis
About 39.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.23. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellink AB had not issued any dividends in recent years. The entity had 4:1 split on the 10th of January 2020. BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.The quote for Cellink AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Cellink AB please contact Erik Gatenholm at 46 7 08 30 08 90 or go to https://www.bico.com.Currently Active Assets on Macroaxis
Other Information on Investing in Cellink Pink Sheet
Cellink AB financial ratios help investors to determine whether Cellink Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.